PGP and cancer: Cancer cells overexpressing P-glycoprotein (P-gp), involved in the reprogramming of many metabolic pathways and resistance to chemotherapy, secreted EVs capable of transferring P-gp-associated multidrug resistance phenotype to surrounding drug-sensitive cancer cells [22].